These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11164757)

  • 1. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects.
    Zubieta JK; Taylor SF; Huguelet P; Koeppe RA; Kilbourn MR; Frey KA
    Biol Psychiatry; 2001 Jan; 49(2):110-6. PubMed ID: 11164757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates.
    Zubieta JK; Huguelet P; Ohl LE; Koeppe RA; Kilbourn MR; Carr JM; Giordani BJ; Frey KA
    Am J Psychiatry; 2000 Oct; 157(10):1619-28. PubMed ID: 11007716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA
    Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.
    Meyer P; Bohnen NI; Minoshima S; Koeppe RA; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
    Neurology; 1999 Jul; 53(2):371-4. PubMed ID: 10430428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet vesicular monoamine transporter density in adult schizophrenia patients.
    Zucker M; Valevski A; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):343-7. PubMed ID: 12126874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
    J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
    Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE
    Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased ventral striatal monoaminergic innervation in Tourette syndrome.
    Albin RL; Koeppe RA; Bohnen NI; Nichols TE; Meyer P; Wernette K; Minoshima S; Kilbourn MR; Frey KA
    Neurology; 2003 Aug; 61(3):310-5. PubMed ID: 12913189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography.
    Gilman S; Koeppe RA; Adams KM; Junck L; Kluin KJ; Johnson-Greene D; Martorello S; Heumann M; Bandekar R
    Ann Neurol; 1998 Sep; 44(3):326-33. PubMed ID: 9749598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the vesicular monoamine transporter.
    Frey KA; Koeppe RA; Kilbourn MR
    Adv Neurol; 2001; 86():237-47. PubMed ID: 11553983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
    De La Fuente-Fernández R; Furtado S; Guttman M; Furukawa Y; Lee CS; Calne DB; Ruth TJ; Stoessl AJ
    Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
    Gilman S; Frey KA; Koeppe RA; Junck L; Little R; Vander Borght TM; Lohman M; Martorello S; Lee LC; Jewett DM; Kilbourn MR
    Ann Neurol; 1996 Dec; 40(6):885-92. PubMed ID: 9007093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
    Chan GL; Holden JE; Stoessl AJ; Samii A; Doudet DJ; Dobko T; Morrison KS; Adam M; Schulzer M; Calne DB; Ruth TJ
    J Nucl Med; 1999 Feb; 40(2):283-9. PubMed ID: 10025836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased striatal monoaminergic terminals in Huntington disease.
    Bohnen NI; Koeppe RA; Meyer P; Ficaro E; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
    Neurology; 2000 May; 54(9):1753-9. PubMed ID: 10802780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L; Crooks PA; Dwoskin LP
    J Neurochem; 1998 Jul; 71(1):258-65. PubMed ID: 9648873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.